Hong Kong (HSI) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Aug 24, 2025

Discover Hong Kong Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the HSI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.

45 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
8049
Jilin Province Huinan Changlong Bio-pharmacy
HK$2.150%50.3%HK$1.2bn/aPE6xn/a12.6%
2877
China Shineway Pharmaceutical Group
HK$8.320.6%3.1%HK$6.3bHK$8.68PE6.9xE8.5%12.4%
239
Pak Fah Yeow International
HK$2.40-1.2%3.0%HK$747.9mn/aPE10.5xn/a7.7%
2161
JBM (Healthcare)
HK$3.044.8%226.9%HK$2.5bHK$3.31PE12.5xE15.9%7.6%
2633
Jacobson Pharma
HK$1.492.8%156.9%HK$3.0bn/aPE9.9xn/a7.4%
3737
Zhongzhi Pharmaceutical Holdings
HK$0.811.3%-12.0%HK$699.5mn/aPE6.7xn/a6.1%
2005
SSY Group
HK$3.02-1.9%-14.0%HK$8.9bHK$5.11PE8.4xE8.7%5.8%
2348
Dawnrays Pharmaceutical (Holdings)
HK$1.29-4.4%16.2%HK$1.9bn/aPE10.1xn/a4.9%
1681
Consun Pharmaceutical Group
HK$14.609.6%158.0%HK$12.1bHK$14.19PE11xE11.6%4.5%
6826
Shanghai Haohai Biological Technology
HK$29.320.3%-1.4%HK$13.1bHK$42.64PE15.5xE14.3%4.5%
719
Shandong Xinhua Pharmaceutical
HK$7.83-2.6%48.3%HK$10.4bn/aPE11.2xS6.7%3.8%
3613
Beijing Tong Ren Tang Chinese Medicine
HK$9.18-0.6%6.5%HK$7.7bHK$11.15PE14.9xE14.7%3.8%
1666
Tong Ren Tang Technologies
HK$5.28-0.9%7.1%HK$6.8bHK$6.16PE11.9xE8.5%3.7%
3933
United Laboratories International Holdings
HK$16.744.8%98.6%HK$33.0bHK$17.08PE11.4xE2.6%3.6%
8329
Shenzhen Neptunus Interlong Bio-technique
HK$0.15-3.8%4.1%HK$258.4mn/aPE38.4xn/a3.5%
950
Lee's Pharmaceutical Holdings
HK$1.85-14.0%50.4%HK$1.1bn/aPE11.7xn/a2.7%
512
Grand Pharmaceutical Group
HK$9.7015.6%131.0%HK$34.0bHK$12.44PE16.3xE12.3%2.7%
1093
CSPC Pharmaceutical Group
HK$10.51-4.1%122.7%HK$120.2bHK$9.89PE28.6xE13.6%2.5%
3320
China Resources Pharmaceutical Group
HK$5.13-3.0%-5.0%HK$32.2bHK$6.78PE8.9xE9.3%2.2%
867
China Medical System Holdings
HK$13.44-0.4%94.2%HK$32.5bHK$13.90PE18xE14.8%2.2%
1061
Essex Bio-Technology
HK$5.67-3.4%139.2%HK$3.2bHK$6.84PE10.5xE12.0%2.1%
690
Uni-Bio Science Group
HK$0.1610.3%201.9%HK$955.4mn/aPE11.5xn/a1.7%
1349
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$3.85-4.0%113.9%HK$9.1bn/aPS5.3xn/a1.7%
2096
Simcere Pharmaceutical Group
HK$14.1013.3%167.0%HK$34.9bHK$15.76PE36.3xE24.4%1.2%
Page 1 of 2